Reactive Thrombocytosis, or elevated blood platelet counts, may predict underlying disease and mortality risk and has been linked with poorer prognosis in COVID-19 patients. Explore in OTR.
Explore augmented underwriting and the evolving role of the underwriter and the continued importance of human expertise in the future of risk assessment. Learn more.
What would happen if your loved one suffered a serious debilitating illness? Could you weather the storm? Learn more about the vital role of Critical Illness (CI) insurance.
Get an unparalleled perspective on underwriting amid a pandemic with ALU’s comprehensive survey. Look back on how carriers responded and explore the challenges ahead. Learn more.